Verax gets CE Mark clearance for platelet test

09/30/2008 | Pharmaceutical Business Review Online

Verax Biomedical has obtained European clearance for its Platelet PGD test, which is designed to rapidly spot bacterial contaminants in blood cells and tissue. The device, which has also secured 510(k) clearance from the FDA, could be used to boost the safety of the blood supply, the company said.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT